The cell line is not validated yet.
XXMUFAe001-A
General
iPSC Line |
|
| hPSCreg name | XXMUFAe001-A |
| Cite as: | XXMUFAe001-A |
| iPSC line type | Human embryonic stem cell (hESC) |
| Similar iPSC lines | No similar lines found. |
| Last update | 10th August 2026 |
| User feedback | |
Provider |
|
| Generator | The First Affiliated Hospital of Xinxiang Medical University (XXMUFA) |
General iPSC Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
Donor Information
General Donor Information |
|
| Sex | female |
| Ethnicity | Ethics Committee of the First Affiliated Hospital of Henan Medical University |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed. |
| Disease associated phenotypes |
|
Karyotyping (Donor) |
|
| Has the donor karyotype been analysed? |
Yes
Karyotyping method:
G-Banding
|
External Databases (Donor) |
|
| BioSamples | SAMEA123300137 |
Ethics
| Was the embryo established purely for research purposes? | Yes |
| Have both parents consented to the use of the embryo for ESC derivation? | Yes |
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
| Was the consent voluntarily given? | Yes |
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
| Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised |
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
| * Does consent expressly prevent the derivation of pluripotent stem cells? | No |
| * Does consent pertain to a specific research project? | No |
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | Yes |
| How may genetic information associated with the cell line be accessed? | Controlled Access |
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | No |
hESC Derivation
| Date of derivation | 2024-10-01 |
| Supernumerary embryos from IVF treatment? |
No
Other hESC source:
H9
|
| PGD Embryo? |
No |
iPSC Culture Conditions
| Medium |
Essential 8™
|
iPSC Characterisation
Analysis of undifferentiated iPSCs
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| NANOG |
Yes |
|
| Marker | Present | Absent |
| mCpG | ||
| OCT4 | X |
Report
Genotyping
Karyotyping (iPSC Line) |
|
| Has the iPSC line karyotype been analysed? |
Yes
46,XX
|
Other Genotyping (iPSC Line) |
|
Login to share your feedback, experiences or results with the research community.